Home 5 Articles 5 Beware of Backlash When Restructuring Commission Arrangements for EKRA Sales Commissions & EKRA Liability Risks

Beware of Backlash When Restructuring Commission Arrangements for EKRA Sales Commissions & EKRA Liability Risks

by | Nov 21, 2021

The following is an excerpt from the Master Guide to Clinical Lab Compliance 2021 Edition available here. To comply with EKRA, labs have been eliminating traditional commissions and bonuses from contracts with sales and marketing staff. A recent federal case is an illustration of the kind of complications and backlash this can engender. The case […]

The following is an excerpt from the Master Guide to Clinical Lab Compliance 2021 Edition available here. To comply with EKRA, labs have been eliminating traditional commissions and bonuses from contracts with sales and marketing staff. A recent federal case is an illustration of the kind of complications and backlash this can engender. The case […]

This content is Exclusive to Lab Compliance Advisor Subscribers

Subscribe or Log in for Exclusive Access.